Lilly says rebates more than offset list price increases for Humalog

Despite a 52% increase in the list price of Humalog insulin lispro in 2014-18, Lilly said the net price it received actually decreased by 8% over the period due to rebates and fees provided to insurers and PBMs.

Eli Lilly and Co. (NYSE:LLY) said Humalog's list price increased from $391 to $594 in 2014-18, while the net price decreased from $147 to $137...